LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target

被引：4
|
作者：
Li, Yijie [1 ,2 ,3 ,4 ,5 ]
Liu, Fenglin [6 ]
Cai, Yunzhou [1 ,2 ,3 ,4 ,5 ]
Yang, Yanqing [1 ,2 ,3 ,4 ,5 ]
Wang, Yuehong [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Cent South Univ, Hunan Key Lab Oral Hlth Res, Changsha 410008, Peoples R China
[2] Cent South Univ, Hunan 3D Printing Engn Res Ctr Oral Care, Changsha 410008, Peoples R China
[3] Cent South Univ, Hunan Clin Res Ctr Oral Major Dis & Oral Hlth, Changsha 410008, Peoples R China
[4] Cent South Univ, Academician Workstn Oral Maxillofacial & Regenera, Changsha 410008, Peoples R China
[5] Cent South Univ, Xiangya Sch Stomatol, Changsha 410008, Peoples R China
[6] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Peoples R China
来源：
CRYSTALS | 2021年 / 11卷 / 03期
基金：
中国国家自然科学基金;
关键词：
fibrosis; long noncoding RNAs; MALAT1; pathogenic mechanism; LONG NONCODING RNA; TO-MESENCHYMAL TRANSITION; INDUCED INTERSTITIAL FIBROSIS; METABOLOMICS; INJURY; INFLAMMATION; SUPPRESSION; DYSFUNCTION; MECHANISMS; REGULATOR;
D O I：
10.3390/cryst11030249
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
Due to the lack of an effective method for the treatment of fibrosis, there are numerous patients suffering from the effects of fibrosis. Severe fibrosis can cause dysfunction of relevant organs characterized by excessive deposition of extracellular matrix components. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA that is widely expressed and highly conserved in human tissues. It can regulate gene expression at various molecular levels, involved in the fibrosis of the liver, heart, lung, and kidney. In this review, we first described the pathogenesis by which MALAT1 promotes fibrosis. Furthermore, we summarized current studies of MALAT1 in the fibrosis of various organs. Hope this review will contribute to a better understanding of the molecular mechanism of fibrosis and the potential of MALAT1 as a novel therapeutic target for fibrosis.
引用
收藏
页码：1 / 16
页数：16
相关论文
共 50 条
  • [41] SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
    Tamang, Suraksha
    Acharya, Varnali
    Roy, Deepronil
    Sharma, Rinka
    Aryaa, Apeksha
    Sharma, Uttam
    Khandelwal, Akanksha
    Prakash, Hridayesh
    Vasquez, Karen M.
    Jain, Aklank
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [42] LncRNA MALAT1 Affects Mycoplasma pneumoniae Pneumonia via NF-κB Regulation
    Gu, Haiyan
    Zhu, Yifan
    Zhou, Yao
    Huang, Tianyu
    Zhang, Siqing
    Zhao, Deyu
    Liu, Feng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [43] LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204
    Li, Jipeng
    Wang, Jianhua
    Chen, Yin
    Li, Shanfeng
    Jin, Mingwei
    Wang, Huaying
    Chen, Zhe
    Yu, Wanjun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (05): : 1099 - +
  • [44] LncRNA MALAT1 Regulates Hyperglycemia Induced EMT in Keratinocyte via miR-205
    Zhang, Liping
    Hung, George Chu-Chih
    Meng, Songmei
    Evans, Robin
    Xu, Junwang
    NON-CODING RNA, 2023, 9 (01)
  • [45] Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV-associated liver fibrosis
    Chan, Kristy Kwan-Shuen
    Hon, Tsz-Chun
    Au, Kwan-Yung
    Choi, Hiu-Lam
    Wong, Danny Ka-Ho
    Chan, Albert Chi-Yan
    Yuen, Man-Fung
    Lai, Ching-Lung
    Lo, Regina Cheuk-Lam
    JOURNAL OF PATHOLOGY, 2022, 257 (02) : 227 - 238
  • [46] Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects
    Qiao, Feng-Hua
    Tu, Min
    Liu, Hong-Yan
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [47] Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells
    Leti, Fatjon
    Legendre, Christophe
    Still, Christopher D.
    Chu, Xin
    Petrick, Anthony
    Gerhard, Glenn S.
    Distefano, Johanna K.
    TRANSLATIONAL RESEARCH, 2017, 190 : 25 - 39
  • [48] The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target
    Jiang, Xiaoying
    Ning, Qilan
    JOURNAL OF DRUG TARGETING, 2020, 28 (10) : 1012 - 1017
  • [49] A genetic variant in the promoter of lncRNA MALAT1 is related to susceptibility of ischemic stroke
    Wang, Yan
    Gu, Xi-Xi
    Huang, Hua-Tuo
    Liu, Chun-Hong
    Wei, Ye-Sheng
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [50] Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer
    Zhao, Kexin
    Jin, Si
    Wei, Bo
    Cao, Shiqiong
    Xiong, Zhifan
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6257 - 6261
12345